Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas G Norwitz

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Neuroscience|September 9, 2020
mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in NeurodegenerationNicholas G Norwitz, Henry Querfurth
Frontiers in Medicine|May 1, 2020
A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic DietNicholas G Norwitz, Vyvyane Loh
Frontiers in Psychiatry|March 1, 2021
Nutrition as Metabolic Treatment for AnxietyNicholas G Norwitz, Uma Naidoo
Metabolites|January 26, 2024
Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover ExperimentNicholas G Norwitz, William C Cromwell
Frontiers in Nutrition|September 19, 2024
Case report: Carnivore-ketogenic diet for the treatment of inflammatory bowel disease: a case series of 10 patientsNicholas G Norwitz, Adrian Soto-Mota
Current Opinion in Endocrinology, Diabetes, and Obesity|August 8, 2022
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experimentDavid Feldman, Siobhan Huggins, Nicholas G Norwitz
Metabolites|September 23, 2022
A Company Is Only as Healthy as Its Workers: A 6-Month Metabolic Health Management Pilot Program Improves Employee Health and Contributes to Cost SavingsNicholas G Norwitz, Adrian Soto-Mota, Tro Kalayjian
Biochemical Society Transactions|February 26, 2020
Why a d-β-hydroxybutyrate monoester?Adrian Soto-Mota, Nicholas G Norwitz, Kieran Clarke
Diseases (Basel, Switzerland)|May 26, 2026
Seven Years of 700 Cholesterol Without Coronary Atherosclerosis: A Lean Mass Hyper-Responder Case ReportNicholas G Norwitz, David Feldman, Adrian Soto-Mota
Frontiers in Nutrition|May 30, 2019
The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's DiseaseNicholas G Norwitz, Michele T Hu, Kieran Clarke
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Neuroscience|September 9, 2020
mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in NeurodegenerationNicholas G Norwitz, Henry Querfurth
Frontiers in Medicine|May 1, 2020
A Standard Lipid Panel Is Insufficient for the Care of a Patient on a High-Fat, Low-Carbohydrate Ketogenic DietNicholas G Norwitz, Vyvyane Loh
Frontiers in Psychiatry|March 1, 2021
Nutrition as Metabolic Treatment for AnxietyNicholas G Norwitz, Uma Naidoo
Metabolites|January 26, 2024
Oreo Cookie Treatment Lowers LDL Cholesterol More Than High-Intensity Statin therapy in a Lean Mass Hyper-Responder on a Ketogenic Diet: A Curious Crossover ExperimentNicholas G Norwitz, William C Cromwell
Frontiers in Nutrition|September 19, 2024
Case report: Carnivore-ketogenic diet for the treatment of inflammatory bowel disease: a case series of 10 patientsNicholas G Norwitz, Adrian Soto-Mota
Current Opinion in Endocrinology, Diabetes, and Obesity|August 8, 2022
Short-term hyper-caloric high-fat feeding on a ketogenic diet can lower low-density lipoprotein cholesterol: the cholesterol drop experimentDavid Feldman, Siobhan Huggins, Nicholas G Norwitz
Metabolites|September 23, 2022
A Company Is Only as Healthy as Its Workers: A 6-Month Metabolic Health Management Pilot Program Improves Employee Health and Contributes to Cost SavingsNicholas G Norwitz, Adrian Soto-Mota, Tro Kalayjian
Biochemical Society Transactions|February 26, 2020
Why a d-β-hydroxybutyrate monoester?Adrian Soto-Mota, Nicholas G Norwitz, Kieran Clarke
Diseases (Basel, Switzerland)|May 26, 2026
Seven Years of 700 Cholesterol Without Coronary Atherosclerosis: A Lean Mass Hyper-Responder Case ReportNicholas G Norwitz, David Feldman, Adrian Soto-Mota
Frontiers in Nutrition|May 30, 2019
The Mechanisms by Which the Ketone Body D-β-Hydroxybutyrate May Improve the Multiple Cellular Pathologies of Parkinson's DiseaseNicholas G Norwitz, Michele T Hu, Kieran Clarke
Pageof 5